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Staphylococcus aureus is an important human pathogen causing nosocomial and
community-acquired infections worldwide. In the characterization of this opportunistic
pathogen, DNA microarray hybridization technique is used as an alternative to sequence
based genotyping to obtain a comprehensive assessment on the virulence, resistance
determinants, and population structure. The objective of this study was to characterize
a defined collection of S. aureus isolates from Nigeria using the microarray technique,
and to assess the extent that it correlates with sequence-based genotyping methods.
The clonal diversity and genomic content of 52 methicillin-susceptible Staphylococcus
aureus (MSSA) were investigated by spa typing, MLST and DNAmicroarray hybridization.
More than half (55.8%) of these isolates were associated with clonal complexes (CCs)
typically associated with methicillin-resistant S. aureus (MRSA) clones i.e., CC1, CC5,
CC8, CC30, and CC45. Certain genes linkedwith virulence (hlgA and clfA) and adherence
(ebpS, fnbA, sspA, sspB, and sspP) were detected in all isolates. A number of genes
or gene clusters were associated with distinct clonal types. The enterotoxin gene
cluster (egc) was linked with CC5, CC25, CC30, CC45, and CC121, enterotoxin H
gene (seh) with CC1, exfoliative toxin D gene (etd) with CC25 and CC80, and the
epidermal cell differentiation inhibitor B gene (edinB) with CC25, CC80, and CC152. The
excellent agreement between data from DNA microarray and MLST in the delineation of
Nigerian MSSA isolates indicates that the microarray technique is a useful tool to provide
information on antibiotic resistance, clonal diversity and virulence factors associated with
infection and disease.
Keywords: Staphylococcus aureus, microarray, MLST, genotyping, Nigeria
Abbreviations: Agr, accessory gene regulator; CC, Clonal complex; CLSI, Clinical Laboratory Standards Institute; MSSA,
Methicillin susceptible Staphylococcus aureus; MLST, Multilocus sequence typing; PVL, Panton-Valentine Leukocidin;
S.aureus, Staphylococcus aureus; SCCmec, Staphylococcal chromosome cassette mec; spa, Staphylococcus aureus protein A;
ST, Sequence Type.
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INTRODUCTION
Staphylococcus aureus is implicated in a variety of human
infections with high rates of morbidity and mortality (Lowy,
1998; Corey, 2009). In infection, S. aureus exhibits a coordinated
and regulated expression for a wide variety of cell and surface-
associated virulence factors (Foster and Höök, 1998; Novick,
2006). These factorsmediate adherence to host cells and damaged
tissue, facilitate tissue destruction and spreading, promote iron
uptake and evasion of host immune system, as well as tissue
damage (Skaar and Schneewind, 2004; Grumann et al., 2014).
Recent studies in Cameroon (Kihla et al., 2014), Egypt (Ahmed
et al., 2014), Gabon (Alabi et al., 2013), Nigeria (Jido and Garba,
2012; Oladeinde et al., 2013), South Africa (Groome et al., 2012;
Naidoo et al., 2013), and Tanzania (Kayange et al., 2010; Mhada
et al., 2012) have identified S. aureus as the main etiological
agent for various infections in Africa. Moreover, this species
has been recognized as one main cause of community-acquired
neonatal sepsis in Africa (Waters et al., 2011). These studies
clearly establish the important role of this major human pathogen
in tropical Africa.
In many health care institutions in sub-Saharan Africa,
the lack of skilled laboratory manpower and resources is a
major constraint in the identification of bacterial pathogens
from clinical samples. If such analysis can be provided at all,
identification of S. aureus typically relies on phenotypic methods
precluding in-depth strain characterization. Molecular analysis
of clonal attribution and presence of single genes contained
in S. aureus isolates have emerged in pilot studies from select
African centers, areas and populations (Ateba Ngoa et al., 2012;
Shittu et al., 2012; Seni et al., 2013; Aiken et al., 2014; Egyir
et al., 2014; Oosthuysen et al., 2014; Conceição et al., 2015; De
Boeck et al., 2015; Kraef et al., 2015; Schaumburg et al., 2015).
Nevertheless, in view of the impact of S. aureus disease in sub-
Saharan Africa, the clonal characterization in concert with a
comprehensive analysis of the hitherto ill-described virulence
factor armamentarium of S. aureus isolates from this region is
urgently warranted. Such analyses should target a broad spectrum
of variable staphylococcal factors such as genes or gene clusters
conferring antibiotic resistance, toxins, virulence, adhesion or
immune evasion factors. These analyses have not been performed
on a collection of S. aureus isolates in Nigeria, and reports from
African countries are limited and only addressed a limited and
select analytical spectrum (Raji et al., 2013; Aiken et al., 2014;
Rovira et al., 2015).
The DNA microarray used for this analysis is a unique and
comprehensive genotyping technique based on the analysis of
334 target sequences corresponding to approximately 170 distinct
genes and their allelic variants. It enables the simultaneous
identification of various gene classes including species markers,
genes encoding resistance and virulence properties, exotoxin and
adhesion factors, accessory gene regulator (agr), capsule, and
SCCmec types (Monecke et al., 2011). Based on the observation
of a high level of genetic diversity from previous investigations
on methicillin-susceptible S. aureus (MSSA) in Nigeria (Shittu
et al., 2011, 2012; Kolawole et al., 2013), we studied MSSA
isolates obtained from various clinical sources in Nigeria using
this comprehensive, array-based approach to provide an insight
on the major factors associated with infection and disease.
MATERIALS AND METHODS
Identification and Antibiotic Susceptibility
Testing of S. aureus Isolates
The isolates (n = 52) were obtained from samples processed
as part of surveillance activities in the microbiology laboratories
of six health care institutions located in Ado-Ekiti, Ile-
Ife, Osogbo, Lagos, and Ibadan in South-West Nigeria, and
Maiduguri in North-East Nigeria. The duration of collection
of isolates was from March 2009 to April, 2010. Only the
isolates were analyzed in this study. Preliminary verification
as S. aureus was based on colony characteristics on blood
agar, positive results for catalase, coagulase and DNase tests.
Twelve isolates from a previous study (Shittu et al., 2011)
were also included in this investigation. Identification was
confirmed byMatrix-Assisted Laser Desorption/Ionization-Time
Of Flight analysis (MALDI-TOF). Susceptibility testing to
penicillin (10 units), cefoxitin (30µg), doxycycline (30µg),
erythromycin (15µg), clindamycin (2µg), gentamicin (10µg),
chloramphenicol (30µg), and trimethoprim-sulfamethoxazole
(1.25/23.75µg) were determined using the disk diffusion
method according to the Clinical Laboratory Standards Institute
guidelines (Clinical and Laboratory Standards Institute (CLSI),
2009).
DNA Extraction
S. aureus genomic DNA was extracted from an 18–24 h old
culture on sheep blood agar using lysis buffer and lysis enhancer
(StaphyType Kit, Alere Technologies GmbH, Jena, Germany)
and processed using a DNeasy tissue kit (Qiagen, Hilden,
Germany).
Molecular Typing of the Isolates
Typing of S. aureuswas based on sequencing of the hypervariable
region of the protein A gene (spa). The spa types were determined
using the Ridom StaphType software (Ridom GmbH, Würzburg,
Germany, version 2.1.1) (Harmsen et al., 2003). Multilocus
sequence typing (MLST) was performed for one isolate of each
spa type (Enright et al., 2000), as a spa type usually belongs to
one sequence type (ST) with few exceptions due to homoplasies
(Basset et al., 2009, 2012). The allelic profiles and STs were
assigned using the MLST S. aureus database (www.mlst.net), and
the sequence types of the remaining isolates were inferred from
the derived MLST data.
DNA Microarray Hybridization
The DNA microarray of the StaphyType™ kit (Alere
Technologies GmbH, Jena, Germany) was used in this study
according to previously established protocols (Monecke et al.,
2008). The isolates were grouped with various clonal complexes
(CCs) by the imaging software Iconoclust based on comparison
of hybridization profiles to a collection of reference strains
previously characterized by MLST.
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Splits Graph Construction
The SplitsTree algorithm (Huson and Bryant, 2006) and software
was used to analyze the similarities between hybridization
patterns, and network tree construction was performed using
SplitsTree 4.10 on default settings (characters transformation,
uncorrected P; distance transformation, Neighbor-Net; and
variance, ordinary least squares).
RESULTS
Identification of S. aureus Isolates
A total of 52 MSSA (3 and 49 isolates from nasal and clinical
sources, respectively) were analyzed (Table 1). The clinical
isolates were obtained from wounds and associated infections
(n = 29; 59.2%), urinary tract infections (n = 6; 12.2%),
semen/infertility diagnosis (n = 4; 8.2%), ocular infections (n =
3; 6.1%), and pneumonia (n = 2; 4.1%). One isolate each was
from otitis media, and blood related infections, while information
on three isolates was not available. The clinical isolates were
obtained from health care institutions located in Ile-Ife (n = 26;
53.1%), Osogbo (n = 11; 22.4%), Maiduguri (n = 5; 10.2%),
Lagos (n = 4; 8.2%), Ibadan, and Ado-Ekiti (n = 2 isolates each:
4.1%).
Antibiotic Susceptibility Testing
All the isolates were susceptible to cefoxitin and 98.1% (n =
51) were resistant to penicillin. Only two isolates each exhibited
resistance to chloramphenicol and gentamicin, and four to
doxycycline. Intermediate susceptibility to clindamycin and
erythromycin were identified in six and 21 isolates, respectively.
The predominant antibiotype was resistance only to penicillin
(n = 23; 44.2%), and resistance to penicillin with intermediate
susceptibility to erythromycin (n = 10; 19.2%) (Table 1).
Sequence based Typing (spa and MLST)
A total of 26 spa types were identified among the 52 MSSA
isolates and the most common were t318 (n = 7), t311 (n = 5),
t084, t127, and t2304 (n = 4 each). Based on MLST, the MSSA
were classified into 13 sequence types (STs) (Table 1).
DNA Microarray Analysis
The assay confirmed the identity of the isolates (S. aureus) by
positive results for specific markers including rndD1 (domain 1
of 23S rRNA), protein A (spa), glyceraldehyde 3-phosphate
dehydrogenase (gapA), catalase A (katA), thermostable
nuclease (nuc), and staphylococcal accessory regulator A
(sarA) (Supplementary Materials 1, 2). The hybridization profiles
revealed that the 52 MSSA isolates clustered in 12 different CCs.
More than half (55.8%) of the CCs were associated with the
genetic background common to the major methicillin-resistant
S. aureus (MRSA) clones i.e., CC1 (n = 6 isolates), CC5 (n = 9),
CC8 (n = 4), CC30 (n = 8), and CC45 (n = 2). The rest were
assigned with CC7 (n = 1), CC15 (n = 7), CC25 (n = 2), CC80
(n = 1), CC97 (n = 1), CC121 (n = 8), and CC152 (n = 3).
Antibiotic Resistance Genes
A total of 69.2% (n = 36) of the isolates yielded a hybridization
signal for the beta-lactamase gene (blaZ) and only 10 and
three isolates were positive for the tetracycline resistance
genes (tetK and tetM), respectively. The two MSSA in CC8
which exhibited phenotypic resistance to chloramphenicol and
gentamicin possessed the corresponding resistance genes (cat
and aacA-aphD). In addition, the single CC80 isolate was positive
for the lincosamide resistance gene (lnuA).
Accessory Gene Regulator and Capsular
Typing
The distribution of agr/CCs/capsule types for the MSSA is
indicated in Figure 1. Overall, 13 (25%) isolates assigned to
different clonal lineages (CC7, CC8, CC25, CC45, CC97, and
CC152) were associated with agr group I, 16 (30.2%; CC5 and
CC15) with group II, and 15 (28.8%; CC1, CC30 and CC80)
with group III. CC121 was the only representative for agr group
IV (n = 8; 15.4%) (Table 1). The capsule type 8 was the most
frequent and detected in 33 (63.5%) isolates affiliated with CC1,
CC7, CC15, CC30, CC45, CC80, and CC121. The remaining
isolates (20; 38.5%) belonged to capsule type 5 (assigned with
CC5, CC8, CC25, CC97, and CC152).
Enterotoxin Genes
PVL-positive isolates (n = 27) belonged to CC1, CC5, CC15,
CC30, CC80, CC121, and CC152 (Supplementary Material 1).
Moreover, the lukF gene (haemolysin gamma; component B) was
universally detected in all the CCs and the lukE genes was a
common feature except with MSSA isolates in CC30, CC45, and
CC152 (Supplementary Material 3). With respect to the carriage
of superantigen genes, only three MSSA (one isolate in CC1 and
two in CC45) tested positive for the toxic shock syndrome toxin
gene (tst-1) (Supplementary Material 1). All the isolates in this
study lacked a hybridization signal for the enterotoxin E gene
(see Supplementary Material 2) and the enterotoxin genes were
not detected in MSSA assigned with CC80, CC97, and CC152. In
the haemolysin gene family, almost all (98.1%) the isolates in the
various CCs possessed the haemolysin alpha and delta genes (hla,
hld), while the haemolysin beta gene (hlb) was identified in the
various CCs except in CC15, CC45, and CC152.
Microbial Surface Components
Recognizing Adhesive Matrix Molecule
(MSCRAMM) Genes
All the isolates were negative for the surface protein involved in
biofilm production (bap), but possessed the genes for the inter-
cellular adhesion protein (icaA/C/D) (CC152 isolates were icaC
negative). The genes for clumping factor A (clfA), cell surface
elastin binding protein (ebpS), fibronectin-binding protein A
(fnbA) and proteases (sspA, sspB, and sspP) were detected in all
the isolates (Supplementary Materials 1, 3).
Splits Tree Analysis
The analysis identified four main clusters (CC5/CC25;
CC8/CC97; CC1/CC7/CC80, and CC30/CC45) indicating
the phylogenetic relationship between the isolates (Figure 2).
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TABLE 1 | Characterization of the methicillin-susceptible S. aureus (MSSA) from Nigeria based on antibiotyping, microarray analysis, spa typing, and
MLST.
Isolate Number Location Sample/Clinical diagnosis Antibiogram Score (%) (Alere) agr/Clonal complex (Alere) spa type MLST
11486_24 Ile-Ife Wound Infection PEN 93.8 agr_III/CC1 t127¶ ST1
AB5_28 Osogbo UTI PEN, ERY(i) 92.8 agr_III/CC1 t127 ST1
Aro_29 Osogbo Semen PEN 94.3 agr_III/CC1 t127 ST1
MD16_4 Not available Not available PEN 94.3 agr_III/CC1 t127 ST1
MD20_8* Maiduguri Wound infection PEN, ERY(i), CC(i) 93.5 agr_III/CC1 t321¶ ST1
6056_34 Osogbo Urine PEN 93.9 agr_III/CC1 t10433¶ ST1
5675_6 Ile-Ife Abscess PEN 91.8 agr_II/CC5 t311 ST5
5221_7 Ile-Ife Urine PEN, ERY(i), SXT(i) 93.8 agr_II/CC5 t311 ST5
D23_15 Ile-Ife Pneumonia PEN 92.8 agr_II/CC5 t311 ST5
D42_17 Ile-Ife Adenocarcinoma PEN, ERY(i) 92.4 agr_II/CC5 t311 ST5
D46_18 Ile-Ife Wound Infection PEN, ERY(i) 92.2 agr_II/CC5 t311¶ ST5
1423_36 Osogbo Urine PEN, ERY(i) 93.8 agr_II/CC5 t442¶ ST5
D19_14 Ile-Ife Not available PEN 93.5 agr_II/CC5 t688¶ ST5
Asu29_27 Osogbo Otitis media PEN, DO, ERY(i) 91.9 agr_II/CC5 t1277¶ ST5
3211_30 Osogbo Wound Infection PEN 92.9 agr_II/CC5 t3235¶ ST5
6773_11 Ile-Ife Wound Infection PEN 93.6 agr_I/CC7 t091¶ ST789
N37_19 Ile-Ife Erythematous lesion PEN, SXT 90 agr_I/CC8 t064¶ ST2427
UC45_37 Ibadan Eye swab PEN, GM, CHL, SXT 91.3 agr_I/CC8 t2658¶ ST2427
55_40 Ado-Ekiti Wound Infection PEN, DO(i), GM, CHL, SXT 90.3 agr_I/CC8 t2658 ST2427
OS39_13* Lagos Semen/Infertility PEN, DO(i), SXT 91.7 agr_I/CC8 t951¶ ST8
11450_23 Ile-Ife Sputum PEN 92.9 agr_II/CC15 t084 ST15
5189_1 Ile-Ife Advanced Cancer PEN 94 agr_II/CC15 t084 ST15
189_2 Ile-Ife Blood PEN, DO(i), ERY(i) 93.9 agr_II/CC15 t084¶ ST15
4013_14* Ile-Ife Wound infection PEN 94.9 agr_II/CC15 t084 ST15
5828_5 Ile-Ife Abscess susceptible to all antibiotics tested 94.4 agr_II/CC15 t2216¶ ST15
MD7_3* Maiduguri Semen/Infertility PEN, ERY(i) 94.6 agr_II/CC15 t2216 ST15
MD19_11* Maiduguri Wound infection PEN 94.4 agr_II/CC15 t2216 ST15
S13_6* Lagos Urinary Tract Infection PEN, ERY(i), SXT 93.1 agr_I/CC25 t3772¶ ST25
3925_32 Osogbo Wound Infection PEN, ERY(i), SXT 91.4 agr_I/CC25 t10183¶ ST25
6073_3 Not available Not available PEN, DO 91.7 agr_III/CC30 t017¶ ST30
D30_16 Ile-Ife Cholecystitis PEN 94.7 agr_III/CC30 t318¶ ST30
6506_2 Osogbo Wound Infection PEN, ERY(i), CC(i) 91.4 agr_III/CC30 t318 ST30
NS7708_22 Ile-Ife Nasal swab/screening PEN, ERY(i) 94.7 agr_III/CC30 t318 ST30
54_39 Ado-Ekiti Wound Infection PEN 94.4 agr_III/CC30 t318 ST30
S12_7* Lagos Wound infection PEN, ERY(i) 93.8 agr_III/CC30 t318 ST30
OS41_10* Lagos Wound infection PEN 93.1 agr_III/CC30 t318 ST30
6330_4 Ile-Ife Osteomyelitis PEN 94.3 agr_III/CC30 t318 ST30
NS2907_21 Ile-Ife Nasal swab/screening PEN, ERY(i), CC(i) 91.8 agr_I/CC45 t095¶ ST508
3950_33 Osogbo Urine PEN 91.5 agr_I/CC45 t10434¶ ST508
GDC_35 Osogbo Semen PEN 94.9 agr_III /CC80 t934¶ ST80
MD14_2* Maiduguri Wound infection PEN, DO(i) 92.9 agr_I/CC97 t458¶ ST97
ZU_26 Ile-Ife Unavailable PEN, ERY(i) 89.3 agr_IV/CC121 t159¶ ST121
UC47_38 Ibadan Eye swab PEN, DO, ERY(i), CC(i) 92.1 agr_IV/CC121 t159 ST121
W10_5* Ile-Ife Wound infection PEN, ERY(i) 91.8 agr_IV/CC121 t314¶ ST121
MD_9* Maiduguri Wound infection PEN, ERY(i), CC(i) 92.1 agr_IV/CC121 t314 ST121
6376_3 Ile-Ife Abscess PEN, DO(i) 93.1 agr_IV/CC121 t2304¶ ST121
6540_10 Ile-Ife Bone Marrow Infection PEN 93.5 agr_IV/CC121 t2304 ST121
NS2986_20 Ile-Ife Nasal swab/screening PEN, DO, ERY(i), CC(i), SXT(i) 92.8 agr_IV/CC121 t2304 ST121
3920_31 Osogbo Aspirate PEN 92.8 agr_IV/CC121 t2304 ST121
D3_12 Ile-Ife Cervical cancer PEN, ERY(i) 94.6 agr_I/ST152 t355¶ ST152
(Continued)
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TABLE 1 | Continued
Isolate Number Location Sample/Clinical diagnosis Antibiogram Score (%) (Alere) agr/Clonal complex (Alere) spa type MLST
D12_13 Ile-Ife Ocular infection PEN 94.6 agr_I/ST152 t355 ST152
W7.2_4* Ile-Ife Wound infection PEN 96.3 agr_I/ST152 t355 ST152
*S. aureus analyzed in a previous study; (i): intermediate susceptibility; agr, accessory gene regulator; PEN, Penicillin; DO, Doxycycline; ERY, Erythromycin; CLI, Clindamycin; GEN,
Gentamicin; CHL, Chloramphenicol; SXT, trimethoprim/sulfamethoxazole; CC, Clonal Complex; ST, Sequence type.
¶spa types selected for Multilocus sequence typing (MLST); Sequence types (STs) of the remaining isolates were inferred from the derived MLST data.
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3 agrIII/CC1/capsule type 8 
agrII/CC5/capsule type 5 
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agrII/CC15/capsule type 8 
agrI/CC25/capsule type 5 
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FIGURE 1 | Distribution of agr/CCs/capsule type of MSSA in Nigeria.
DISCUSSION
We observed a complete agreement between DNA microarray
analysis and MLST in the delineation of the isolates (Table 1),
showing that the hybridization profile could be used to predict
the lineages. Furthermore, the heterogeneous and divergent
nature of the isolates observed in this study provided evidence
on the overall higher diversity of MSSA compared with MRSA
(Deurenberg and Stobberingh, 2008; Goering et al., 2008;
Ghasemzadeh-Moghaddam et al., 2011; Ruffing et al., 2012;
Blomfeldt et al., 2013; Rasmussen et al., 2013, 2014). In Nigeria,
many diagnostic microbiology laboratories rely on the disc
diffusion technique for antibiotic susceptibility testing, but this
protocol does not provide information on the nature of resistance
genes. The antibiotic susceptibility results observed in this study
were in accordance with the corresponding resistance gene
profiles by DNA microarray. MSSA isolates that exhibited full
resistance to trimethoprim-sulfamethoxazole clustered with CC8
and CC25, but were dfrS1 negative indicating that a different
mechanism could be attributed to resistance. A recent study
(Nurjadi et al., 2014) has provided strong evidence that the dfrG
gene is the predominant trimethoprim resistance determinant on
S. aureus in Africa. Overall, resistant determinants for antibiotics,
heavy metal and quaternary ammonium compounds were
observed more often in CC8 than other CCs (Supplementary
Materials 1, 3).
The accessory gene regulator (agr) and capsule typing
methods are useful front-line tools for the characterization of S.
aureus (Goerke et al., 2005). Hybridization signals for agr type I
and IV were observed for one, three, and four isolates grouped
with CC25, CC152, and CC121, respectively (Supplementary
Materials 1, 2). This could be attributed to possible cross-
hybridization as the alleles for the two agr types are closely related
(Monecke et al., 2010). Our observations on CCs and agr groups
were similar to previous reports on MSSA in five major African
towns (Breurec et al., 2010), Gabon (Ateba Ngoa et al., 2012),
and Nigeria (Ghebremedhin et al., 2009; Kolawole et al., 2013).
In addition, our study also support the view (Wright et al., 2005;
Holtfreter et al., 2007; Rasmussen et al., 2014) that an agr type
may be detected in isolates which are assigned to genetically
diverse CCs, whereas, it is also associated with specific CCs. The
dominance of capsule type 8 in MSSA is consistent with data
from Gabon (Schaumburg et al., 2011), Norway (Blomfeldt et al.,
2013), and Sweden (Rasmussen et al., 2013, 2014).
Staphylococcal enterotoxins are typically encoded by genes
located on mobile genetic elements (Baba et al., 2002). The egc
cluster (seg+sei+sem+sen+seo+seu) is located on the genomic
island vSAβ and reported to be associated with specific clonal
types regardless of the geographical strain distribution (Lindsay
and Holden, 2006). In this investigation, the egc-enterotoxin
gene cluster was a unique feature for CC5, CC25, CC30, CC45,
and CC121. Previous studies have indicated that the cluster
is predominantly present in MSSA assigned with CC5, CC25,
CC30, and CC45 (Van Trijp et al., 2010; Rasmussen et al., 2013).
The seh gene is linked to the staphylococcal cassette chromosome
mec (SCCmec elements) and reported to be restricted to the
CC1 genomic background (Baba et al., 2002). Moreover, the seh
gene has also been reported mainly in MSSA-CC30 (Blomfeldt
et al., 2013). Nevertheless, our observation on seh-positiveMSSA-
CC1 is in agreement with previous reports (Chen et al., 2013;
Rasmussen et al., 2013).
The genes associated with staphylococcal complement
inhibitor (scn) and staphylokinase (sak) were also widely
distributed across the CCs but CC15 isolates were sak gene
negative. Virulence associated with the exfoliative toxins has
been identified to cause epidermal cleavage in staphylococcal
scalded skin syndrome (SSSS) and bullous impetigo (Ladhani
et al., 1999). The exfoliative toxin D (ETD) is a 27-kDa protein
which causes epidermal blisters in newborn mice (Yamasaki
et al., 2006). The epidermal cell differentiation factors (EDIN)
target and inhibit the small host protein RhoA, a master regulator
of the host cell actin cytoskeleton (Inoue et al., 1991; Jaffe and
Hall, 2005; Aktories, 2011). Furthermore, the edin-isoform
(edinB) and etd genes are located in tandem in a S. aureus etd
pathogenicity island in a chromosome of etd-positive S. aureus
strains (Yamaguchi et al., 2002). A strong association of the
etd gene with invasive CC25 S. aureus isolates has also been
Frontiers in Microbiology | www.frontiersin.org 5 October 2015 | Volume 6 | Article 1160
Shittu et al. Molecular profiling of Nigerian MSSA
edinB gene 
eta gene 
tst-1 gene 
edinB gene 
etd gene 
PVL gene edinB gene 
PVL gene 
tst-1 gene 
*PVL gene 
CC121/agrIV 
CC152/agrI 
CC45/agrI 
CC30/agrII 
CC7/agrI 
CC80/agrIII 
CC1/agrIII 
seh gene 
CC97/agrI 
CC8/agrI 
CC5/agrII 
CC25/agrI 
* All the isolates in the clonal complexes were positive for the different virulence genes 
CC15/agrII 
FIGURE 2 | Splits tree graph based on hybridization profile of the MSSA isolates. The results of all array hybridization experiments were arranged in a matrix.
Columns represent the target genes and the rows represent the number of experiments; 1, positive; 0, negative; −, ambiguous. Converted to “sequences”: 1, c; 0,
g; −, c.
reported. In this study, all the isolates assigned with CC25 and
CC80 were etd-positive, which is in agreement with a previous
study in Nigeria (Shittu et al., 2011). Moreover, MSSA grouped
with CC25, CC80, and CC152 were edinB positive but CC152
isolates were etd negative. Our observations were similar to a
study on the distribution of the edin gene in S. aureus from
diabetic foot ulcers (Messad et al., 2013). A study in MSSA
bacteremia isolates in Sweden showed that the collagen binding
protein (Cna) was detected in CC1, CC30, and CC45. Our report
identified the gene in isolates assigned with CC1, CC30, CC45,
CC121, and CC152.
Our study has a number of limitations. Although all isolates
were of human origin, and the large majority was obtained
from clinical samples, a clear distinction between commensal
and clinical strains could not be made based on the available
information. An association of isolates within the context of
endemicity i.e., nosocomial vs. community associated infections,
is also not clear. Furthermore, whereas the microarray analytical
database is exhaustive, well-characterized, and validated with
isolates from all continents, the attribution of CCs is based on the
hybridization reactions and resulting microarray profile rather
than gene sequencing, and a positive signal does not necessarily
imply the presence of gene product (e.g., protein). In addition,
the microarray method was unable to separate ST8 from ST2427.
This might be due to the close phylogenetic relation of both STs
as they are single locus variants (ST8: 3−3−1−1−4−4−3 and
ST2427: 3−3−297−1−4−4−3). Finally, with a collection of 52
isolates studied, and a large number of genes and genetic profile
ascertained by microarray, the potential for individual statistical
comparisons is limited. Yet, with this comprehensive genetic-
analytical approach performed on a clinical isolate collection
obtained from patients of various medical institutions in a
sub-Saharan African country, Nigeria, a number of important
observations could be made which clearly characterize and
demarcate the clonal distribution as well as the virulence gene
equipment.
More than one half (55.8%; n = 29) of these MSSA
isolates were associated with a genetic background which is
attributable to classic methicillin-resistant S. aureus (MRSA)
clones. PVL-positive isolates were identified in seven of the 12
CCs. Moreover, toxin genes were observed to be distributed
mainly with certain clonal types, and in agreement with previous
investigations (Holtfreter et al., 2007; Monecke et al., 2008).
Antibiotic resistance gene profiles of the isolates by the DNA
microarray demonstrated concordant results with data on
antibiotic susceptibility testing. The array-based, comprehensive
approach has been shown to yield such diverse CC and gene
specific results on an isolate collection from sub-Saharan Africa.
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Overall, microarray analysis proved to be a useful tool to
provide useful information on antibiotic resistance, population
structure and various virulence factor profiles associated with
infection and disease. It is assumed that these findings might
be useful for a better understanding of clinical staphylococcal
disease presentation, patient care and for assistance in outbreak
investigation in health care institutions in a country such as
Nigeria. Moreover, our study also underlines the need for further
trials employing well-controlled, prospectively collected clinical
isolates to delineate the genetic pathogen profile in conjunction
with the clinical disease presentation in sub-Saharan Africa.
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